These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 20194307)

  • 1. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
    Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
    Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
    Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
    Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice.
    Sumitomo-Ueda Y; Aihara K; Ise T; Yoshida S; Ikeda Y; Uemoto R; Yagi S; Iwase T; Ishikawa K; Hirata Y; Akaike M; Sata M; Kato S; Matsumoto T
    Hypertension; 2010 Sep; 56(3):430-6. PubMed ID: 20660821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.
    Rosón MI; Della Penna SL; Cao G; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
    J Cell Physiol; 2010 Jul; 224(1):41-8. PubMed ID: 20232302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
    Whaley-Connell A; Govindarajan G; Habibi J; Hayden MR; Cooper SA; Wei Y; Ma L; Qazi M; Link D; Karuparthi PR; Stump C; Ferrario C; Sowers JR
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E355-63. PubMed ID: 17440033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neferine mitigates angiotensin II-induced atrial fibrillation and fibrosis via upregulation of Nrf2/HO-1 and inhibition of TGF-β/p-Smad2/3 pathways.
    Jiang XX; Zhang R; Wang HS
    Aging (Albany NY); 2024 May; 16(10):8630-8644. PubMed ID: 38775722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitavastatin restores vascular dysfunction in insulin-resistant state by inhibiting NAD(P)H oxidase activity and uncoupled endothelial nitric oxide synthase-dependent superoxide production.
    Shinozaki K; Nishio Y; Ayajiki K; Yoshida Y; Masada M; Kashiwagi A; Okamura T
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):122-30. PubMed ID: 17414223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
    Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
    Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
    Banday AA; Lokhandwala MF
    Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling.
    Tsai CT; Lai LP; Kuo KT; Hwang JJ; Hsieh CS; Hsu KL; Tseng CD; Tseng YZ; Chiang FT; Lin JL
    Circulation; 2008 Jan; 117(3):344-55. PubMed ID: 18172037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation.
    Adam O; Lavall D; Theobald K; Hohl M; Grube M; Ameling S; Sussman MA; Rosenkranz S; Kroemer HK; Schäfers HJ; Böhm M; Laufs U
    J Am Coll Cardiol; 2010 Feb; 55(5):469-80. PubMed ID: 20117462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling.
    Ikeda Y; Aihara K; Yoshida S; Sato T; Yagi S; Iwase T; Sumitomo Y; Ise T; Ishikawa K; Azuma H; Akaike M; Kato S; Matsumoto T
    Endocrinology; 2009 Jun; 150(6):2857-64. PubMed ID: 19196803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries.
    Cousin M; Custaud MA; Baron-Menguy C; Toutain B; Dumont O; Guihot AL; Vessières E; Subra JF; Henrion D; Loufrani L
    Hypertension; 2010 Jan; 55(1):109-15. PubMed ID: 19948989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II upregulates Kv1.5 expression through ROS-dependent transforming growth factor-beta1 and extracellular signal-regulated kinase 1/2 signalings in neonatal rat atrial myocytes.
    Lu G; Xu S; Peng L; Huang Z; Wang Y; Gao X
    Biochem Biophys Res Commun; 2014 Nov; 454(3):410-6. PubMed ID: 25451261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
    Yang J; Zhu HH; Chen GP; Ye Y; Zhao CZ; Mou Y; Hu SJ
    Int J Biochem Cell Biol; 2013 Mar; 45(3):657-66. PubMed ID: 23277274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes.
    Yeh YH; Kuo CT; Chan TH; Chang GJ; Qi XY; Tsai F; Nattel S; Chen WJ
    Cardiovasc Res; 2011 Jul; 91(1):62-70. PubMed ID: 21289011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
    Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
    Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
    Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY
    Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of reactive oxygen species in hypothalamic paraventricular nucleus attenuates the renin-angiotensin system and proinflammatory cytokines in hypertension.
    Su Q; Qin DN; Wang FX; Ren J; Li HB; Zhang M; Yang Q; Miao YW; Yu XJ; Qi J; Zhu Z; Zhu GQ; Kang YM
    Toxicol Appl Pharmacol; 2014 Apr; 276(2):115-20. PubMed ID: 24576725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts.
    An SJ; Boyd R; Zhu M; Chapman A; Pimentel DR; Wang HD
    Cardiovasc Res; 2007 Sep; 75(4):702-9. PubMed ID: 17391658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.